+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Beta Interferon"

From
Beta Interferon - Global Strategic Business Report - Product Thumbnail Image

Beta Interferon - Global Strategic Business Report

  • Report
  • April 2025
  • 93 Pages
  • Global
From
From
Interferon - Global Strategic Business Report - Product Thumbnail Image

Interferon - Global Strategic Business Report

  • Report
  • April 2025
  • 78 Pages
  • Global
From
Interferons Market Report 2025 - Product Thumbnail Image

Interferons Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Interferons Market 2024-2028 - Product Thumbnail Image

Interferons Market 2024-2028

  • Report
  • March 2024
  • 160 Pages
  • Global
From
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Beta Interferon is a type of biotechnology drug used to treat multiple sclerosis (MS). It is a synthetic form of a naturally occurring protein that helps to reduce inflammation and slow the progression of MS. Beta Interferon is administered through injections and is used to reduce the frequency of MS relapses. It is also used to reduce the severity of symptoms and slow the progression of disability. Beta Interferon is one of the most widely used treatments for MS, and is often prescribed in combination with other therapies. It is also used to treat other neurological conditions, such as chronic inflammatory demyelinating polyneuropathy. The Beta Interferon market is highly competitive, with several major players offering a range of products. Companies in the market include Biogen, Merck, Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more